Research News and Research

RSS

State Roundup: Setting up health insurance exchanges; Community-based clinics cuts; Autism legislation; End-of-life care

The board of the Health Benefit Exchange is going to be small and mighty. ... This exchange will concentrate the health insurance buying power of millions of Californians, and will be the central force in implementing national health care reform in California (Gorn, 2/4).

7 Feb 2011

Acupuncture and exercise help women with PCOS

Acupuncture and physical exercise improve hormone levels and menstrual bleeding pattern in women with polycystic ovary syndrome (PCOS), reveals research from the University of Gothenburg, Sweden.

7 Feb 2011

Viewpoints: (Still) Debating health law's constitutionality; Food labels; Lawmakers' abortion divide

For state governments, the bill presents huge new costs, as we are required to enroll 15 million to 20 million more people in our Medicaid systems. ... Perhaps worse, the law expects to conscript the states as its agents in its takeover of health care. It assumes that we will set up and operate its new insurance "exchanges" for it (Indiana Gov. Mitch Daniels, 2/7).

7 Feb 2011

Harbor BioSciences closes U.S.-based Apoptone Phase I/IIa clinical trial for castration resistant prostate cancer

Harbor BioSciences, Inc., a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory diseases, today announced it is closing the clinical sites of its U.S.-based Phase I/IIa clinical trial with Apoptone® (HE3235) for castration resistant prostate cancer (CRPC) – also referred to as hormone resistant prostate cancer.

7 Feb 2011

CMD co-founder receives Prize4Life award for discovery of new ALS biomarker

Convergence Medical Devices (CMD) today announced that its co-founder, Dr. Seward Rutkove, Chief of the Division of Neuromuscular Disease at Beth Israel Deaconess Medical Center and Associate Professor of Neurology at Harvard Medical School, received Prize4Life's prestigious award for the discovery of a new biomarker for ALS (Amyotrophic Lateral Sclerosis), also known as Lou Gehrig's disease.

7 Feb 2011

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

A low cost, nanometer-sized drug to treat chronic wounds, such as diabetic foot ulcers or burns, has been developed by a group of scientists from the Hebrew University of Jerusalem, Harvard Medical School and others in the U.S. and Japan.

7 Feb 2011

Bruker launches new fully automated and fast toxin identification system

Bruker today announces the North American launch of its compact, fully automated and fast toxin identification system, called pTD™ (portable Toxin Detector), at the American Society for Microbiology (ASM) Bio-Defense and Emerging Diseases Research Meeting in Washington, DC. The novel, benchtop, push-button pTD system is intended for smaller, field and mobile laboratories for use by non-expert operators in homeland security applications.

7 Feb 2011

AB SCIEX, ARUP enter collaboration to develop new clinical research test methods for hormone analysis

AB SCIEX, a global leader in life science analytical technologies, today announced a collaboration with ARUP Laboratories, a major clinical reference laboratory in the United States, to develop new test methods that clinical research laboratories around the world can adopt to improve hormone analysis.

7 Feb 2011

AMRI fourth quarter total revenue increases 12% to $48.6 million

AMRI today reported financial and operating results for the fourth quarter and full year ended December 31, 2010.

7 Feb 2011

First Edition: February 7, 2011

Today's headlines focus on how states face major budget challenges -- with health policy at the heart of the issue.

7 Feb 2011

Proactive chronic care management can reduce hospital admission, readmission rates

Two Healthways Center for Health Research studies recently published in Population Health Management demonstrate that hospital admissions and readmissions can be reduced through chronic care management and proactive interventions, such as telephonic outreach, resulting in considerable cost savings.

7 Feb 2011

Reliv International launches new nutritional supplement to address entire fatigue cycle

Consumers who are fighting the fatigue cycle -- physical fatigue, mental fog and stress -- now have a new means of breaking that cycle. Reliv 24K, a new nutritional supplement, is the first shot to provide healthy energy and greater mental focus while also reducing stress. Reliv International, Inc., a creator of nutritional supplements that promote optimal health, introduced the product last weekend in Atlanta.

7 Feb 2011

Synexus wins first contract to conduct ophthalmology studies

Synexus, the world's largest company responsible for the recruitment and running of clinical trials, has won its first contract to conduct ophthalmology studies.

From AES - Accelerated Enrollment Solutions 7 Feb 2011

Human Vaccines journal publishes paper on Inovio's new DNA vaccine delivery technology

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its new generation DNA vaccine delivery technology, which provides the powerful enabling capabilities of electroporation without contacting the skin, is highlighted in a paper published in the scientific journal Human Vaccines.

7 Feb 2011

Patients with kidney tumours can benefit from nephron-sparing surgery

Patients with kidney tumours larger than four centimetres are much more likely to enjoy good long-term renal function if they undergo nephron-sparing surgery rather than radical nephrectomy, according to a study in the February issue of the urology journal BJUI.

7 Feb 2011

Curaxis President comments on new Alzheimer's Association report

Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp., commented today on a new report by the Alzheimer's Association, titled "Generation Alzheimer's – the defining disease of the baby boomers", which demonstrates the devastating impact and size of Alzheimer's disease.

7 Feb 2011

Court filings: Tobacco companies seek to block public disclosure of proposed statements

According to court filings, the tobacco companies are seeking to block public disclosure of proposed statements a federal judge has ordered them to make to correct their deceptions about their deadly products.

7 Feb 2011

Baden-W-rttemberg's study and research to be presented at AAAS Annual Meeting 2011

Baden-W-rttemberg, the German Southwest, is the most innovative region in Europe, particularly dedicated to science and education. A share of 4.4 % of the State's GDP is invested in research and development - more than in most countries all around the world. Baden-W-rttemberg offers the highest density of research institutions and universities in Germany.

7 Feb 2011

Allergies appear to reduce glioma risk

The more allergies one has, the lower the risk of developing low- and high-grade glioma, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

7 Feb 2011

Pediatric physicians present 12 research abstracts, posters at Cardiology 2011

Pediatric cardiology researchers and clinicians gather this week in Scottsdale, Ariz. for Cardiology 2011, the 15th Annual Update on Pediatric and Congenital Cardiovascular Disease, sponsored by The Children's Hospital of Philadelphia. Original research from more than 30 cardiac programs in the U.S. and abroad is being presented throughout the meeting.

7 Feb 2011

Research News and Research

State Roundup: Setting up health insurance exchanges; Community-based clinics cuts; Autism legislation; End-of-life care

Acupuncture and exercise help women with PCOS

Viewpoints: (Still) Debating health law's constitutionality; Food labels; Lawmakers' abortion divide

Harbor BioSciences closes U.S.-based Apoptone Phase I/IIa clinical trial for castration resistant prostate cancer

CMD co-founder receives Prize4Life award for discovery of new ALS biomarker

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

Bruker launches new fully automated and fast toxin identification system

AB SCIEX, ARUP enter collaboration to develop new clinical research test methods for hormone analysis

AMRI fourth quarter total revenue increases 12% to $48.6 million

First Edition: February 7, 2011

Proactive chronic care management can reduce hospital admission, readmission rates

Reliv International launches new nutritional supplement to address entire fatigue cycle

Synexus wins first contract to conduct ophthalmology studies

Human Vaccines journal publishes paper on Inovio's new DNA vaccine delivery technology

Patients with kidney tumours can benefit from nephron-sparing surgery

Curaxis President comments on new Alzheimer's Association report

Court filings: Tobacco companies seek to block public disclosure of proposed statements

Baden-W-rttemberg's study and research to be presented at AAAS Annual Meeting 2011

Allergies appear to reduce glioma risk

Pediatric physicians present 12 research abstracts, posters at Cardiology 2011

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News